COSCIENS Biopharma Inc. is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. COSCIENS Biopharma Inc., formerly known as Aeterna Zentaris Inc., is based in TORONTO, ONTARIO.
| Revenue (Most Recent Fiscal Year) | $9.59M |
| Net Income (Most Recent Fiscal Year) | $-15.31M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.73 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.34 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -152.67% |
| Net Margin (Trailing 12 Months) | -164.63% |
| Return on Equity (Trailing 12 Months) | -168.04% |
| Return on Assets (Trailing 12 Months) | -50.69% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.47 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.03 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 2.28 |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.49 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-4.73 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 3.18M |
| Free Float | 3.18M |
| Market Capitalization | $6.65M |
| Average Volume (Last 20 Days) | 1503.55 |
| Beta (Past 60 Months) | 0.61 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.10% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.73% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |